{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T21:13:54Z","timestamp":1772399634093,"version":"3.50.1"},"reference-count":16,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Genentech Inc. (South San Francisco, CA, USA). Support for editorial assistance was funded by Genentech Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2017,4,3]]},"DOI":"10.1080\/10428194.2016.1213824","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T21:15:54Z","timestamp":1471036554000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice"],"prefix":"10.1080","volume":"58","author":[{"given":"Ida","family":"Wong-Sefidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Byrtek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Zelenetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0283"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.040"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701422059"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1539-5"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.0736"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2079-y"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2007.n.005"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.0934"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)70008-0"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1495"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.6546"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Maurer MJ, Ghesquieres H, Ansell SM, et\u00a0al. 1664 event-free survival at 12 months (EFS12) from diagnosis is a robust endpoint for disease-related survival in patients with follicular lymphoma in the immunochemotherapy era. 56th ASH Annual Meeting; 2014: Session 622, Poster I.","DOI":"10.1182\/blood.V124.21.1664.1664"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1213824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1213824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:29:46Z","timestamp":1601008186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2016.1213824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,5]]},"published-print":{"date-parts":[[2017,4,3]]}},"alternative-id":["10.1080\/10428194.2016.1213824"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2016.1213824","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}